Deborah Card

4.1k total citations · 1 hit paper
21 papers, 2.3k citations indexed

About

Deborah Card is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Deborah Card has authored 21 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Physiology. Recurrent topics in Deborah Card's work include Sphingolipid Metabolism and Signaling (11 papers), Lipid Membrane Structure and Behavior (7 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Deborah Card is often cited by papers focused on Sphingolipid Metabolism and Signaling (11 papers), Lipid Membrane Structure and Behavior (7 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Deborah Card collaborates with scholars based in United States, Japan and Australia. Deborah Card's co-authors include James D. Bergstrom, Mark Rosenbach, Gan-Ju Shei, James A. Milligan, Jeffrey J. Hale, Suzanne Mandala, Richard Hajdu, Hugh Rosen, Christopher L. Lynch and Rosemary Thornton and has published in prestigious journals such as Science, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Deborah Card

21 papers receiving 2.3k citations

Hit Papers

Alteration of Lymphocyte Trafficking by Sphingosine-1-Pho... 2002 2026 2010 2018 2002 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
    2002 1.4k citations Suzanne Mandala, Richard Hajdu et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah Card United States 17 1.6k 687 283 277 275 21 2.3k
Eva E. Prieschl Austria 19 1.6k 1.0× 654 1.0× 202 0.7× 309 1.1× 174 0.6× 26 2.2k
Kathleen M. Rupprecht United States 13 1.6k 1.0× 478 0.7× 142 0.5× 242 0.9× 230 0.8× 20 2.0k
Grisha Pirianov United Kingdom 23 2.1k 1.3× 506 0.7× 490 1.7× 615 2.2× 98 0.4× 39 3.2k
Shawn G. Payne United States 20 2.6k 1.6× 371 0.5× 254 0.9× 800 2.9× 107 0.4× 24 2.9k
Steven W. Paugh United States 18 2.1k 1.3× 536 0.8× 185 0.7× 708 2.6× 72 0.3× 26 2.6k
Peter Heining Switzerland 10 1.1k 0.7× 320 0.5× 121 0.4× 194 0.7× 100 0.4× 13 1.6k
Benjamin J. Pettus United States 18 2.5k 1.6× 381 0.6× 158 0.6× 644 2.3× 125 0.5× 20 2.8k
Christine Loh United States 17 997 0.6× 297 0.4× 319 1.1× 157 0.6× 80 0.3× 34 1.6k
Michiko Tamba Japan 17 1.5k 1.0× 173 0.3× 390 1.4× 223 0.8× 83 0.3× 21 2.8k
Kazuyuki Kitatani Japan 29 2.1k 1.3× 351 0.5× 202 0.7× 641 2.3× 124 0.5× 76 2.9k

Countries citing papers authored by Deborah Card

Since Specialization
Citations

This map shows the geographic impact of Deborah Card's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Card with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Card more than expected).

Fields of papers citing papers by Deborah Card

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Card. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Card. The network helps show where Deborah Card may publish in the future.

Co-authorship network of co-authors of Deborah Card

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Card. A scholar is included among the top collaborators of Deborah Card based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Card. Deborah Card is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adams, Sylvia, Sherene Loi, Deborah Toppmeyer, et al.. (2017). Phase 2 study of pembrolizumab as first-line therapy for PD-L1–positive metastatic triple-negative breast cancer (mTNBC): Preliminary data from KEYNOTE-086 cohort B.. Journal of Clinical Oncology. 35(15_suppl). 1088–1088. 55 indexed citations
2.
Adams, Sylvia, Peter Schmid, Hope S. Rugo, et al.. (2017). Phase 2 study of pembrolizumab (pembro) monotherapy for previously treated metastatic triple-negative breast cancer (mTNBC): KEYNOTE-086 cohort A.. Journal of Clinical Oncology. 35(15_suppl). 1008–1008. 90 indexed citations
3.
Sun, Hong, John Palcza, Deborah Card, et al.. (2016). Effects of Suvorexant, an Orexin Receptor Antagonist, on Respiration during Sleep In Patients with Obstructive Sleep Apnea. Journal of Clinical Sleep Medicine. 12(1). 9–17. 60 indexed citations
4.
Adams, Sylvia, Deborah Card, Jing Zhao, Vassiliki Karantza, & Gursel Aktan. (2016). Abstract OT1-03-20: A phase 2 study of pembrolizumab (MK-3475) monotherapy for metastatic triple-negative breast cancer (mTNBC): KEYNOTE-086. Cancer Research. 76(4_Supplement). OT1–3. 8 indexed citations
5.
Troyer, Matthew D., Naoto Uemura, John Palcza, et al.. (2014). Respiratory Safety of the Orexin Receptor Antagonist Suvorexant during Sleep In Patients with Compromised Respiratory Function and in Healthy Subjects (P5.293). Neurology. 82(10_supplement). 1 indexed citations
6.
Singh, Sheo B., Weiguo Liu, Xiaohua Li, et al.. (2012). Antifungal Spectrum, In Vivo Efficacy, and Structure–Activity Relationship of Ilicicolin H. ACS Medicinal Chemistry Letters. 3(10). 814–817. 52 indexed citations
7.
Yan, Lin, George Doherty, Jeffrey J. Hale, et al.. (2006). Discovery of 3-arylpropionic acids as potent agonists of sphingosine-1-phosphate receptor-1 (S1P1) with high selectivity against all other known S1P receptor subtypes. Bioorganic & Medicinal Chemistry Letters. 16(14). 3679–3683. 15 indexed citations
8.
Colandrea, Vincent J., Lin Yan, Jeffrey J. Hale, et al.. (2006). 2,5-Disubstituted pyrrolidine carboxylates as potent, orally active sphingosine-1-phosphate (S1P) receptor agonists. Bioorganic & Medicinal Chemistry Letters. 16(11). 2905–2908. 18 indexed citations
9.
Yan, Lin, Richard J. Budhu, Christopher L. Lynch, et al.. (2006). 2-Aryl(pyrrolidin-4-yl)acetic acids are potent agonists of sphingosine-1-phosphate (S1P) receptors. Bioorganic & Medicinal Chemistry Letters. 16(13). 3564–3568. 18 indexed citations
10.
Yan, Lin, Jeffrey J. Hale, Sander G. Mills, et al.. (2006). SAR studies of 3-arylpropionic acids as potent and selective agonists of sphingosine-1-phosphate receptor-1 (S1P1) with enhanced pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 17(3). 828–831. 18 indexed citations
11.
Hale, Jeffrey J., William Neway, Sander G. Mills, et al.. (2004). Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720. Bioorganic & Medicinal Chemistry Letters. 14(12). 3351–3355. 64 indexed citations
12.
Hale, Jeffrey J., Lin Yan, William Neway, et al.. (2004). Synthesis, stereochemical determination and biochemical characterization of the enantiomeric phosphate esters of the novel immunosuppressive agent FTY720. Bioorganic & Medicinal Chemistry. 12(18). 4803–4807. 39 indexed citations
13.
Hale, Jeffrey J., George Doherty, Sander G. Mills, et al.. (2004). Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists. Bioorganic & Medicinal Chemistry Letters. 14(13). 3501–3505. 39 indexed citations
14.
Hale, Jeffrey J., George Doherty, Sander G. Mills, et al.. (2004). The discovery of 3-(N-alkyl)aminopropylphosphonic acids as potent S1P receptor agonists. Bioorganic & Medicinal Chemistry Letters. 14(13). 3495–3499. 26 indexed citations
15.
Yan, Lin, Jeffrey J. Hale, Christopher L. Lynch, et al.. (2004). Design and synthesis of conformationally constrained 3-(N-alkylamino)propylphosphonic acids as potent agonists of sphingosine-1-phosphate (S1P) receptors. Bioorganic & Medicinal Chemistry Letters. 14(19). 4861–4866. 23 indexed citations
16.
Hale, Jeffrey J., Christopher L. Lynch, William Neway, et al.. (2004). A Rational Utilization of High-Throughput Screening Affords Selective, Orally Bioavailable 1-Benzyl-3-carboxyazetidine Sphingosine-1-phosphate-1 Receptor Agonists. Journal of Medicinal Chemistry. 47(27). 6662–6665. 65 indexed citations
17.
Mandala, Suzanne, Richard Hajdu, James D. Bergstrom, et al.. (2002). Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists. Science. 296(5566). 346–349. 1398 indexed citations breakdown →
18.
Detmers, Patricia A., Melba Hernandez, John S. Mudgett, et al.. (2000). Deficiency in Inducible Nitric Oxide Synthase Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice. The Journal of Immunology. 165(6). 3430–3435. 177 indexed citations
19.
Wright, Samuel D., Charlotte Burton, Melba Hernandez, et al.. (2000). Infectious Agents Are Not Necessary for Murine Atherogenesis. The Journal of Experimental Medicine. 191(8). 1437–1442. 137 indexed citations
20.
Fambrough, D M, et al.. (1978). Metabolism of acetylcholine receptors in skeletal muscle.. PubMed. 277–94. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eva E. Prieschl Breakdown of academic impact, for papers by Kathleen M. Rupprecht Breakdown of academic impact, for papers by Grisha Pirianov Breakdown of academic impact, for papers by Shawn G. Payne Breakdown of academic impact, for papers by Steven W. Paugh Breakdown of academic impact, for papers by Peter Heining Breakdown of academic impact, for papers by Benjamin J. Pettus Breakdown of academic impact, for papers by Christine Loh Breakdown of academic impact, for papers by Michiko Tamba Breakdown of academic impact, for papers by Kazuyuki Kitatani
Rankless by CCL
2026